To achieve the goal of eliminating human rabies death of dog-mediated in 2030, many African countries have agreed to a list of rabies as a priority and zoonotic disease control program to perform both short and long term. In this context, local reliable diagnosis is crucial to the success of the pitch control system. However, harmonious, sustainable and supports diagnostic bid has not been achieved on the continent. Herewith, we describe the organization and the results of the proficiency test (PT) for post-mortem diagnosis of rabies in animals, which involved thirteen veterinary laboratory and the laboratory of public health in Africa. Participants were invited to assess both the performance tests Direct Fluorescent Antibody (DFA) and of conventional RT-PCR.
From the results delivered, while thirteen proven laboratory can test samples by DFA test, eleven performed RT-PCR method; ten applied both techniques. Of note, the number of laboratories capable of implementing RT-PCR rabies has increased 4-10 after exercise. Importantly, the results show a higher ability in applying molecular tests compared with the test DFA (concordance, sensitivity and specificity: 98.2%, 96.97% and 100% for RT-PCR; 87.69%, 89.23% and 86.15% for the test DFA), demonstrating the feasibility of molecular methods for the diagnosis of animal pathogens in Africa. Another positive result of this approach is that negative and positive controls were made available for further in house validation of new techniques; In addition, a detailed questionnaire was given to collect useful and relevant information on diagnostic procedures and biosafety measures implemented at the laboratory level.
We illustrate the potential for specialist laboratory networks to be used as a tool preparedness and response through rapid collection and sharing of data. Here, Emerging Viral Diseases Laboratory Network Expert (EVD-LabNet) and laboratory assessment of chikungunya virus (CHIKV) in the European tourist returns associated with ongoing outbreaks in Thailand is used for this purpose. EVD-LabNet quickly collect data laboratory requests, diagnosed CHIKV imported cases and the sequence generated and shared among its members and with the European Center for Disease Prevention and Control.
the perspective of a new laboratory for evaluation of vivax malaria-infected patients: a useful tool for monitoring infection.
In recent years, the number of cases with severe Plasmodium vivax malaria has shown a rising trend. Therefore, it is important to identify the best routine laboratory markers characterize acute phase of the disease and can serve as a tool for clinical follow-up of patients. In a cohort study, we followed 87 patients with acute P. vivax mono obtained in an endemic area of the Brazilian Amazon.
Forty-two of biochemical and hematological parameters are different are often tested in clinical routine evaluated in the acute phase and recovery phase. A total of 42 laboratory tests performed: biochemical parameters measured were serum lipids, aminotransferase, bilirubin, amylase, glucose, urea, creatinine, albumin, globulin, uric acid, C-reactive protein, and alpha-1-acid glycoprotein. hematologic parameters including total and differential white blood cell and platelet counts, hemoglobin concentration, mean platelet volume, platelet distribution width, and plateletcrit.
4" Soft Rubber Brayer |
|||
| M-CTP-BRY1 | MiTeGen | 12 Unit | 24 EUR |
|
Description: 4" Soft Rubber Brayer |
|||
Collagel Hydrogel Soft+-Rat |
|||
| CGH322 | Neuromics | 20ml | 340.8 EUR |
Collagel Hydrogel Soft-Rat |
|||
| CGH321 | Neuromics | 20ml | 325.2 EUR |
Collagel Hydrogel Soft+-Human |
|||
| CGHH322 | Neuromics | 20ml | 763.2 EUR |
Collagel Hydrogel Soft+-Bovine |
|||
| CGHB322 | Neuromics | 20ml | 465.6 EUR |
Soft tissue homogenizing CK14 |
|||
| HOM1044 | Scientific Laboratory Supplies | PK50 | 238.8 EUR |
Collagel Hydrogel Soft-Human |
|||
| CGHH321 | Neuromics | 20ml | 747.6 EUR |
Collagel Hydrogel Soft-Bovine |
|||
| CGHB321 | Neuromics | 20ml | 434.4 EUR |
Loops 10ul soft white Sterile |
|||
| TS1-B | Scientific Laboratory Supplies | PK1000 | 111.6 EUR |
Soft tissue tumor tissue array |
|||
| BC24011b | TissueArray | each | 270 EUR |
|
Description: Soft tissue tumor tissue array, including TNM and clinical stage, 63 cases/63 cores, replacing BC24011a |
|||
Soft tissue sarcoma as control |
|||
| SO809c | TissueArray | each | 270 EUR |
|
Description: Soft tissue sarcoma as control, including TNM, clinical stage and pathology grade, 80 cases/80 cores (core size 1.5mm), replacing SO809b |
|||
Soft tissue tumor tissue array |
|||
| SF961 | TissueArray | each | 222 EUR |
|
Description: Soft tissue tumor tissue array, including TNM and clinical stage, 48 cases/96 cores |
|||
Soft Tissue Tissue Slide (Benign) |
|||
| 12-303-10um | ProSci | 10 um | 241.8 EUR |
Soft Tissue Tissue Slide (Benign) |
|||
| 12-303-4um | ProSci | 4 um | 216.6 EUR |
Soft Tissue Tissue Slide (Abnormal) |
|||
| 12-305-10um | ProSci | 10 um | 241.8 EUR |
Soft Tissue Tissue Slide (Abnormal) |
|||
| 12-305-4um | ProSci | 4 um | 216.6 EUR |
Soft tissue homogenizing CK14-0.5mL |
|||
| HOM1046 | Scientific Laboratory Supplies | PK50 | 238.8 EUR |
Soft tissue homogenizing CK14-WP |
|||
| HOM1104 | Scientific Laboratory Supplies | EACH | 325.2 EUR |
Soft tissue homogenizing CK14-7mL |
|||
| HOM1088 | Scientific Laboratory Supplies | PK50 | 320.4 EUR |
Brush Flat Soft Hair 12mm width |
|||
| BRU2000 | Scientific Laboratory Supplies | EACH | 19.18 EUR |
Brush Flat Soft Hair 25mm width |
|||
| BRU2002 | Scientific Laboratory Supplies | EACH | 19.88 EUR |
Brush Flat Soft Hair 50mm width |
|||
| BRU2004 | Scientific Laboratory Supplies | EACH | 25.15 EUR |
Brush Round Soft Hair 4mm diameter |
|||
| BRU2020 | Scientific Laboratory Supplies | EACH | 5.22 EUR |
Brush Round Soft Hair 6mm diameter |
|||
| BRU2022 | Scientific Laboratory Supplies | EACH | 4.83 EUR |
Brush Round Soft Hair 8mm diameter |
|||
| BRU2024 | Scientific Laboratory Supplies | EACH | 7.83 EUR |
Brush Pencil Soft Hair 1mm diameter |
|||
| BRU2050 | Scientific Laboratory Supplies | EACH | 6.51 EUR |
Brush Pencil Soft Hair 1.5mm diameter |
|||
| BRU2052 | Scientific Laboratory Supplies | EACH | 7.64 EUR |
Brush Pencil Soft Hair 2.5mm diameter |
|||
| BRU2054 | Scientific Laboratory Supplies | EACH | 7.72 EUR |
Brush Pencil Soft Hair 3.5mm diameter |
|||
| BRU2056 | Scientific Laboratory Supplies | EACH | 7.82 EUR |
Brush Pencil Soft Hair 4mm diameter |
|||
| BRU2058 | Scientific Laboratory Supplies | EACH | 10.88 EUR |
Soft tissue cancer test tissue array |
|||
| T241 | TissueArray | each | 48 EUR |
|
Description: Soft tissue cancer test tissue array, with normal soft tissue control tissue, including TNM, clinical stage and pathology grade, 6 cases/24 cores |
|||
Loop Yellow Soft 1ul Bags of 20 |
|||
| TS/4-D | Scientific Laboratory Supplies | PK1000 | 109.2 EUR |
Soft tissue sarcoma test tissue array |
|||
| T243 | TissueArray | each | 66 EUR |
|
Description: Soft tissue sarcoma test tissue array, with normal soft tissue as control, including TNM and clinical stage, 2 serial sections, 6 cases/24 cores (core size 1.5mm) |
|||
Soft tissue sarcoma test tissue array |
|||
| T243a | TissueArray | each | 66 EUR |
|
Description: Soft tissue sarcoma test tissue array,with normal soft tissue as control,TNM/Stage ( AJCC 8th edition), 6 cases/24 cores(corse size 1.5mm) |
|||
Soft tissue malignant tumor tissue array |
|||
| T244 | TissueArray | each | 48 EUR |
|
Description: Soft tissue malignant tumor tissue array, including TNM and clinical stage, 6 cases/24 cores |
|||
Tumors of soft tissue, 102 cases (1.5mm) |
|||
| SFT1021 | Pantomics | 1 | 300 EUR |
|
Description: Soft tissue tumor tissue array, 102 cases of benign and malignant tumors of various soft tissues. |
|||
Tumors of soft tissue, 75 cases (1.1mm) |
|||
| SFT1501 | Pantomics | 1 | 300 EUR |
|
Description: Soft tissue tumor tissue array, 150 cores, 75 cases of benign and malignant tumors of various soft tissues in duplicates. |
|||
Soft Tissue Tissue Slide (Adipose-Normal) |
|||
| 12-311-10um | ProSci | 10 um | 241.8 EUR |
Soft Tissue Tissue Slide (Adipose-Normal) |
|||
| 12-311-4um | ProSci | 4 um | 216.6 EUR |
Soft Tissue Tissue Slide (Adipose-Benign) |
|||
| 12-313-10um | ProSci | 10 um | 241.8 EUR |
Soft Tissue Tissue Slide (Adipose-Benign) |
|||
| 12-313-4um | ProSci | 4 um | 216.6 EUR |
Soft Tissue Tissue Slide (Adipose-Lipoma) |
|||
| 12-314-10um | ProSci | 10 um | 241.8 EUR |
Soft Tissue Tissue Slide (Adipose-Lipoma) |
|||
| 12-314-4um | ProSci | 4 um | 216.6 EUR |
3D Cell Culture Gel, soft (Col-Tgel) |
|||
| P720S-10 | 101Bio | - | Ask for price |
3D Cell Culture Gel, soft (Col-Tgel) |
|||
| P720S-2 | 101Bio | - | Ask for price |
Protein Safe Soft tissue homogenizing CK14 |
|||
| HOM1076 | Scientific Laboratory Supplies | PK50 | 333.6 EUR |
Soft Tissue Tissue Slide (Adipose-Abnormal) |
|||
| 12-317-10um | ProSci | 10 um | 241.8 EUR |
Soft Tissue Tissue Slide (Adipose-Abnormal) |
|||
| 12-317-4um | ProSci | 4 um | 216.6 EUR |
Soft Tissue Tissue Slide (Adipose-Undiagnosed) |
|||
| 12-310-10um | ProSci | 10 um | 241.8 EUR |
Soft Tissue Tissue Slide (Adipose-Undiagnosed) |
|||
| 12-310-4um | ProSci | 4 um | 216.6 EUR |
Soft Tissue Tissue Slide (Adipose-Liposarcoma) |
|||
| 12-316-10um | ProSci | 10 um | 241.8 EUR |
Soft Tissue Tissue Slide (Adipose-Liposarcoma) |
|||
| 12-316-4um | ProSci | 4 um | 216.6 EUR |
Soft tissue tumor with normal tissue array |
|||
| SO801a | TissueArray | each | 306 EUR |
|
Description: Soft tissue tumor with normal tissue array, including TNM and clinical stage, 80 cases/80 cores, replaced by SO801b |
|||
Soft tissue tumor array with autopsy tissue |
|||
| T242b | TissueArray | each | 66 EUR |
|
Description: Soft tissue tumor array with autopsy tissue, including TNM, clinical stage, 12 cases/ 24 cores, replacing T242a |
|||
Diversey Soft Care Fresh Handwashing Cream 800mL |
|||
| SAF5344 | Scientific Laboratory Supplies | PK6 | 78.34 EUR |
Human Soft Tissue Slide (Benign) (5 slides/pk) |
|||
| HTS-12303 | Alpha Diagnostics | 1 pk | 343.2 EUR |
Common diseases of soft tissue, 24 cases (2.5mm) |
|||
| SFD241 | Pantomics | 1 | 228 EUR |
|
Description: Soft tissue disease tissue array, 24 cases of normal, reactive and tumor conditions of various soft tissues |
|||
Common diseases of soft tissue, 24 cases (2mm) |
|||
| SFD481 | Pantomics | 1 | 265.2 EUR |
|
Description: Soft tissue disease tissue array, 24 cases of reactive and tumor conditions of various soft tissues in duplicates. |
|||
Soft Tissue Tissue Slide (Skeletal Muscle-Normal) |
|||
| 12-341-10um | ProSci | 10 um | 241.8 EUR |
Soft Tissue Tissue Slide (Skeletal Muscle-Normal) |
|||
| 12-341-4um | ProSci | 4 um | 216.6 EUR |
Soft Tissue Tissue Slide (Skeletal Muscle-Benign) |
|||
| 12-343-10um | ProSci | 10 um | 241.8 EUR |
Soft Tissue Tissue Slide (Skeletal Muscle-Benign) |
|||
| 12-343-4um | ProSci | 4 um | 216.6 EUR |
Human Soft Tissue Slide (Abnormal) (5 slides/pk) |
|||
| HTS-12305 | Alpha Diagnostics | 1 pk | 343.2 EUR |
Tumors of soft tissue, 48 cases (1.5mm), set 1 |
|||
| SFT961 | Pantomics | 1 | 300 EUR |
|
Description: Soft tissue tumor tissue array, set 1, non-overlapping with SFT962, 96 cores, 48 cases of benign and malignant tumors of various soft tissues in duplicates. |
|||
Tumors of soft tissue, 48 cases (1.5mm), set 2 |
|||
| SFT962 | Pantomics | 1 | 300 EUR |
|
Description: Soft tissue tumor tissue array, set 2, non-overlapping with SFT961, 96 cores, 48 cases of benign and malignant tumors of various soft tissues in duplicates. |
|||
Soft Tissue Tissue Slide (Skeletal Muscle-malignant) |
|||
| 12-345-10um | ProSci | 10 um | 241.8 EUR |
Soft Tissue Tissue Slide (Skeletal Muscle-malignant) |
|||
| 12-345-4um | ProSci | 4 um | 216.6 EUR |
3D Cell Culture Gel 2ml x(soft+medium+hard) |
|||
| P720SMH-6 | 101Bio | - | Ask for price |
Precellys 2mL Lysing Kits - Soft tissue Starter box |
|||
| HOM1060 | Scientific Laboratory Supplies | PK40 | 238.8 EUR |
Diversey Soft Care Wash Mild Hand Wash H2 500mL |
|||
| SAF5380 | Scientific Laboratory Supplies | PK10 | 167.12 EUR |
Soft tissue tumor with adjacent normal tissue array |
|||
| SO241 | TissueArray | each | 66 EUR |
|
Description: Soft tissue tumor with adjacent normal tissue array, including TNM and clinical stage, 12 cases/24 cores |
|||
Human Soft Tissue Slide (Adipose Normal) (5 slides/pk) |
|||
| HTS-12311 | Alpha Diagnostics | 1 pk | 343.2 EUR |
Human Soft Tissue Slide (Adipose Benign) (5 slides/pk) |
|||
| HTS-12313 | Alpha Diagnostics | 1 pk | 343.2 EUR |
Human Soft Tissue Slide (Adipose Lipoma) (5 slides/pk) |
|||
| HTS-12314 | Alpha Diagnostics | 1 pk | 343.2 EUR |
Alveolar Soft Part Sarcoma Chromosome Region, Candidate 1 |
|||
| PR27224 | Neuromics | 2 ug | 229.2 EUR |
Human Soft Tissue Slide (Adipose Abnormal) (5 slides/pk) |
|||
| HTS-12317 | Alpha Diagnostics | 1 pk | 343.2 EUR |
Soft tissue fibrosarcoma tissue array (2013 WHO classification) |
|||
| SO961 | TissueArray | each | 306 EUR |
|
Description: Soft tissue fibrosarcoma tissue array (2013 WHO classification), including TNM and clinical stage (AJCC 7th edition), 96 cases/96 cores |
|||
Human Soft Tissue Slide (Adipose Undiagnosed) (5 slides/pk) |
|||
| HTS-12310 | Alpha Diagnostics | 1 pk | 343.2 EUR |
Human Soft Tissue Slide (Adipose Liposarcoma) (5 slides/pk) |
|||
| HTS-12316 | Alpha Diagnostics | 1 pk | 343.2 EUR |
Multiple sarcoma of soft tissue array with normal tissue |
|||
| SO208a | TissueArray | each | 546 EUR |
|
Description: Multiple sarcoma of soft tissue array with normal tissue, including pathology grade, TNM and clinical stage, 64 cases/192 cores, replacing SO208 |
|||
Diversey Soft Care Dermasoft Moisturising Reconditioning Lotion 800mL |
|||
| SAF5340 | Scientific Laboratory Supplies | PK6 | 116.2 EUR |
Human Soft Tissue Slide (Skeletal Muscle Normal) (5 slides/pk) |
|||
| HTS-12341 | Alpha Diagnostics | 1 pk | 343.2 EUR |
Human Soft Tissue Slide (Skeletal Muscle Benign) (5 slides/pk) |
|||
| HTS-12343 | Alpha Diagnostics | 1 pk | 343.2 EUR |
Alveolar Soft Part Sarcoma Chromosome Region, Candidate 1 Protein |
|||
| 20-abx263361 | Abbexa |
|
|
Soft tissue tumor tissue array with normal tissue as control |
|||
| SO481 | TissueArray | each | 198 EUR |
|
Description: Soft tissue tumor tissue array with normal tissue as control, including TNM and clinical stage, 48 cases/48 cores |
|||
Human Soft Tissue Slide (Skeletal Muscle Malignant) (5 slides/pk) |
|||
| HTS-12345 | Alpha Diagnostics | 1 pk | 343.2 EUR |
NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964) Antibody |
|||
| BNC941964-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964), CF594 conjugate, Concentration: 0.1mg/mL |
|||
NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964) Antibody |
|||
| BNC941964-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964), CF594 conjugate, Concentration: 0.1mg/mL |
|||
NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964) Antibody |
|||
| BNC801964-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964), CF680 conjugate, Concentration: 0.1mg/mL |
|||
NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964) Antibody |
|||
| BNC801964-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964), CF680 conjugate, Concentration: 0.1mg/mL |
|||
NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964) Antibody |
|||
| BNC701964-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964), CF770 conjugate, Concentration: 0.1mg/mL |
|||
NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964) Antibody |
|||
| BNC701964-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964), CF770 conjugate, Concentration: 0.1mg/mL |
|||
NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964) Antibody |
|||
| BNC881964-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964), CF488A conjugate, Concentration: 0.1mg/mL |
|||
NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964) Antibody |
|||
| BNC881964-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964), CF488A conjugate, Concentration: 0.1mg/mL |
|||
NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964) Antibody |
|||
| BNC811964-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964), CF680R conjugate, Concentration: 0.1mg/mL |
|||
NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964) Antibody |
|||
| BNC811964-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964), CF680R conjugate, Concentration: 0.1mg/mL |
|||
NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964) Antibody |
|||
| BNC051964-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964), CF405M conjugate, Concentration: 0.1mg/mL |
|||
NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964) Antibody |
|||
| BNC051964-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964), CF405M conjugate, Concentration: 0.1mg/mL |
|||
NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964) Antibody |
|||
| BNC041964-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964), CF405S conjugate, Concentration: 0.1mg/mL |
|||
NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964) Antibody |
|||
| BNC041964-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964), CF405S conjugate, Concentration: 0.1mg/mL |
|||
NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964) Antibody |
|||
| BNC401964-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964), CF640R conjugate, Concentration: 0.1mg/mL |
|||
NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964) Antibody |
|||
| BNC401964-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964), CF640R conjugate, Concentration: 0.1mg/mL |
|||
NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964) Antibody |
|||
| BNCAP1964-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964) Antibody |
|||
| BNCAP1964-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964) Antibody |
|||
| BNCA1964-250 | Biotium | 250uL | 472.8 EUR |
|
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964), APC conjugate, Concentration: 0.1mg/mL |
|||
NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964) Antibody |
|||
| BNCP1964-250 | Biotium | 250uL | 472.8 EUR |
|
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964), PerCP conjugate, Concentration: 0.1mg/mL |
|||
NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964) Antibody |
|||
| BNCR1964-250 | Biotium | 250uL | 472.8 EUR |
|
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964), RPE conjugate, Concentration: 0.1mg/mL |
|||
NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964) Antibody |
|||
| BNCH1964-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964) Antibody |
|||
| BNCH1964-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964) Antibody |
|||
| BNCB1964-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964), Biotin conjugate, Concentration: 0.1mg/mL |
|||
NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964) Antibody |
|||
| BNCB1964-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964), Biotin conjugate, Concentration: 0.1mg/mL |
|||
NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964) Antibody |
|||
| BNUB1964-100 | Biotium | 100uL | 316.8 EUR |
|
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964), Concentration: 0.2mg/mL |
|||
NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964) Antibody |
|||
| BNUB1964-50 | Biotium | 50uL | 486 EUR |
|
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964), 1mg/mL |
|||
NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964) Antibody |
|||
| BNUB1964-500 | Biotium | 500uL | 615.6 EUR |
|
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964), Concentration: 0.2mg/mL |
|||
NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964) Antibody |
|||
| BNC471964-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964), CF647 conjugate, Concentration: 0.1mg/mL |
|||
NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964) Antibody |
|||
| BNC471964-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964), CF647 conjugate, Concentration: 0.1mg/mL |
|||
NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964) Antibody |
|||
| BNC611964-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964), CF660R conjugate, Concentration: 0.1mg/mL |
|||
NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964) Antibody |
|||
| BNC611964-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964), CF660R conjugate, Concentration: 0.1mg/mL |
|||
NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964) Antibody |
|||
| BNC431964-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964), CF543 conjugate, Concentration: 0.1mg/mL |
|||
NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964) Antibody |
|||
| BNC431964-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964), CF543 conjugate, Concentration: 0.1mg/mL |
|||
NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964) Antibody |
|||
| BNC551964-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964), CF555 conjugate, Concentration: 0.1mg/mL |
|||
NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964) Antibody |
|||
| BNC551964-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964), CF555 conjugate, Concentration: 0.1mg/mL |
|||
NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964) Antibody |
|||
| BNC681964-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964), CF568 conjugate, Concentration: 0.1mg/mL |
|||
NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964) Antibody |
|||
| BNC681964-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964), CF568 conjugate, Concentration: 0.1mg/mL |
|||
NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1997R) Antibody |
|||
| BNC941997-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1997R), CF594 conjugate, Concentration: 0.1mg/mL |
|||
NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1997R) Antibody |
|||
| BNC941997-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1997R), CF594 conjugate, Concentration: 0.1mg/mL |
|||
NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/2550R) Antibody |
|||
| BNC942550-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/2550R), CF594 conjugate, Concentration: 0.1mg/mL |
|||
NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/2550R) Antibody |
|||
| BNC942550-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/2550R), CF594 conjugate, Concentration: 0.1mg/mL |
|||
NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1997R) Antibody |
|||
| BNC801997-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1997R), CF680 conjugate, Concentration: 0.1mg/mL |
|||
NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1997R) Antibody |
|||
| BNC801997-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1997R), CF680 conjugate, Concentration: 0.1mg/mL |
|||
NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/2550R) Antibody |
|||
| BNC802550-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/2550R), CF680 conjugate, Concentration: 0.1mg/mL |
|||
NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/2550R) Antibody |
|||
| BNC802550-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/2550R), CF680 conjugate, Concentration: 0.1mg/mL |
|||
NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1997R) Antibody |
|||
| BNC701997-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1997R), CF770 conjugate, Concentration: 0.1mg/mL |
|||
NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1997R) Antibody |
|||
| BNC701997-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1997R), CF770 conjugate, Concentration: 0.1mg/mL |
|||
NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/2550R) Antibody |
|||
| BNC702550-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/2550R), CF770 conjugate, Concentration: 0.1mg/mL |
|||
NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/2550R) Antibody |
|||
| BNC702550-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/2550R), CF770 conjugate, Concentration: 0.1mg/mL |
|||
NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1997R) Antibody |
|||
| BNC881997-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1997R), CF488A conjugate, Concentration: 0.1mg/mL |
|||
NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1997R) Antibody |
|||
| BNC881997-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1997R), CF488A conjugate, Concentration: 0.1mg/mL |
|||
NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/2550R) Antibody |
|||
| BNC882550-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/2550R), CF488A conjugate, Concentration: 0.1mg/mL |
|||
NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/2550R) Antibody |
|||
| BNC882550-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/2550R), CF488A conjugate, Concentration: 0.1mg/mL |
|||
NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1997R) Antibody |
|||
| BNC811997-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1997R), CF680R conjugate, Concentration: 0.1mg/mL |
|||
NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1997R) Antibody |
|||
| BNC811997-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1997R), CF680R conjugate, Concentration: 0.1mg/mL |
|||
NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/2550R) Antibody |
|||
| BNC812550-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/2550R), CF680R conjugate, Concentration: 0.1mg/mL |
|||
NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/2550R) Antibody |
|||
| BNC812550-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/2550R), CF680R conjugate, Concentration: 0.1mg/mL |
|||
NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1997R) Antibody |
|||
| BNC051997-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1997R), CF405M conjugate, Concentration: 0.1mg/mL |
|||
NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1997R) Antibody |
|||
| BNC051997-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1997R), CF405M conjugate, Concentration: 0.1mg/mL |
|||
NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1997R) Antibody |
|||
| BNC041997-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1997R), CF405S conjugate, Concentration: 0.1mg/mL |
|||
NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1997R) Antibody |
|||
| BNC041997-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1997R), CF405S conjugate, Concentration: 0.1mg/mL |
|||
NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1997R) Antibody |
|||
| BNC401997-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1997R), CF640R conjugate, Concentration: 0.1mg/mL |
|||
NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1997R) Antibody |
|||
| BNC401997-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1997R), CF640R conjugate, Concentration: 0.1mg/mL |
|||
NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/2550R) Antibody |
|||
| BNC402550-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/2550R), CF640R conjugate, Concentration: 0.1mg/mL |
|||
NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/2550R) Antibody |
|||
| BNC402550-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/2550R), CF640R conjugate, Concentration: 0.1mg/mL |
|||
NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/2550R) Antibody |
|||
| BNC052550-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/2550R), CF405M conjugate, Concentration: 0.1mg/mL |
|||
NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/2550R) Antibody |
|||
| BNC052550-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/2550R), CF405M conjugate, Concentration: 0.1mg/mL |
|||
NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/2550R) Antibody |
|||
| BNC042550-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/2550R), CF405S conjugate, Concentration: 0.1mg/mL |
|||
NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/2550R) Antibody |
|||
| BNC042550-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/2550R), CF405S conjugate, Concentration: 0.1mg/mL |
|||
NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1997R) Antibody |
|||
| BNCAP1997-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1997R), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1997R) Antibody |
|||
| BNCAP1997-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1997R), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
Our results show that some biochemical and hematological parameters associated with the acute phase of P. vivax and these parameters returned to normal values in the healing phase. Using this parameter for the diagnosis and follow-up of infection is a useful clinical tool to evaluate the clinical course and response to therapy of patients with uncomplicated malaria vivax.